ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range (82)    NLM QUALITY MEASURE GROUPS (802.3)

Name Value
MEASURE TITLE ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range
CMS ID CMS179v3
VERSION NUMBER 3
DEVELOPER National Committee for Quality Assurance
STEWARD Centers for Medicare & Medicaid Services
COPYRIGHT
Limited proprietary coding is contained in the Measure specifications for 
user convenience. Users of proprietary code sets should obtain all necessary 
licenses from the owners of the code sets.
VALUE SETS
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.202
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1048
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.101.12.1001
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.104.12.1017
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.837
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.213
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113762.1.4.1
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.3591
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.114222.4.11.836
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.117.1.7.1.232
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.560.100.4
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
  • VALUE SET OID:   2.16.840.1.113883.3.464.1003.104.12.1018
    VALUE SET VERSION DATE:   2014-07-01 00:00:00
GUID a5e96a45-8132-4e72-bf4f-e8c81db9e641
NQF NUMBER NA
DESCRIPTION
Average percentage of time in which patients aged 18 and older with atrial 
fibrillation who are on chronic warfarin therapy have International Normalized 
Ratio (INR) test results within the therapeutic range (i.e., TTR) during 
the measurement period.
CATEGORY Individual Characteristic
IDENTIFIER 179
STATUS InProgress
TYPE OUTCOME
MEASURE SET CY 2014 EP